Autoimmune thyroid diseases are associated with thyroid autoantibodies, including several types directed against the TSH receptor. TSH receptor autoantibodies may be stimulatory, mimicking the actions of TSH, as in Graves diesease. Alternatively, they may inhibit TSH binding and block the action of endogenous TSH. Such blocking autoantibodies produce transient neonatal hypothyroidism and chronic atrophic throiditis. TBII, which measures the ability of antibodies to inhibit TSH binding to its receptor, relrects the presence of either or both the stimulatory and inhibitory immunoglobulin classes.
No special preparation is needed for Thyrotropin Binding Inhibitory Immunoglobulin. Inform your doctor if you are on any medications or have any underlying medical conditions or allergies before undergoing Thyrotropin Binding Inhibitory Immunoglobulin. Your doctor depending on your condition will give specific instructions.
|All age groups
|< 16% inhibition